Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone.
Cambodian refugees with posttraumatic stress disorder (PTSD) represent a cohort in severe need of treatment, but little information is available to guide treatment choices. We selected a sample of pharmacotherapy-refractory individuals to test the efficacy of combination treatment with sertraline and cognitive-behavior therapy (CBT) for treating PTSD. Participants in this pilot study were ten Khmer-speaking women who had been at a mean age of 22-26 years during the Pol Pot period (1975-1979). These patients were randomly assigned to either sertraline alone or combined treatment. We found that combined treatment offered additional benefit in the range of medium to large effect sizes for PTSD and associated symptoms. Our findings indicate that substantial gains can be achieved by adding CBT to pharmacotherapy for PTSD, and that a program of CBT emphasizing information, exposure, and cognitive-restructuring can be successfully modified for Khmer-speaking refugees.
Otto
Michael W
MW
Massachusetts General Hospital & Harvard Medical School, WACC 812, 15 Parkman St., Boston, MA 02114, USA. motto@partners.org
Hinton
Devon
D
Korbly
Nicole B
NB
Chea
Andrea
A
Ba
Phalnarith
P
Gershuny
Beth S
BS
Pollack
Mark H
MH
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002160:Cambodia / Q000208:ethnology; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D012036:Refugees; D020280:Sertraline / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic / Q000208:ethnology / Q000628:therapy*; D014481:United States
D000928:Antidepressive Agents; D020280:Sertraline